M&A Deal Summary |
|
|---|---|
| Date | 2024-01-22 |
| Target | Invitae - Reproductive Health Assets |
| Sector | Life Science |
| Buyer(s) | Natera |
| Sellers(s) | Invitae |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Healthcare Services |
| Employees | 4,424 |
| Revenue | 1.7B USD (2024) |
Natera engages in cell-free DNA testing. Natera offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. Natera was founded in 2003 and is based in Austin, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-13 |
Natera - Evercord Cord Blood Business
San Carlos, California, United States Natera, Inc. - Evercord Cord Blood Business helped more than 500 families use their cord blood stem cells for established and experimental medical treatments, more than any other family cord blood bank. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-12-05 |
Foresight Diagnostics
Boulder, Colorado, United States Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) to aid in patient management. Its cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Boulder, Colorado. |
Buy | $450M |
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Life Science |
| Employees | 1,700 |
| Revenue | 516M USD (2022) |
Invitae is a genetic information company diagnostics for hereditary disorders. Invitae was founded in 2010 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 3 of 3 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 3 of 3 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-15 |
YouScript
Seattle, Washington, United States YouScript is a clinical decision support and analytics platform. Its software pairs a patient's pharmacogenetic profile with published drug and gene interaction information to assess the risk of adverse drug events and possible side effects. YouScript was established in 2016 and is based in Seattle, Washington. |
Sell | - |
